Back to today’s briefing

Story perspectives

UCLA Health's GENETECA™ Boosts Genetic Testing Access to 94%

1/16/2025

28 5

Summary

Story summary

UCLA Health's GENETECA™ tool has revolutionized access to genetic testing for cancer patients, skyrocketing from 22% to an impressive 94% in just 18 months. This innovative online platform simplifies consent and testing processes, enabling genetic counselors to dedicate their expertise to patients with positive results, ultimately enhancing personalized medicine and improving treatment outcomes for those battling hereditary cancers.

1 of 1

Story summary

UCLA Health's GENETECA™ tool has revolutionized access to genetic testing for cancer patients, skyrocketing from 22% to an impressive 94% in just 18 months. This innovative online platform simplifies consent and testing processes, enabling genetic counselors to dedicate their expertise to patients with positive results, ultimately enhancing personalized medicine and improving treatment outcomes for those battling hereditary cancers.